Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, April 28, 2022
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
[ Thu, Apr 28th 2022
] - WOPRAI
Daniel Grosslight Downgraded (TDOC) to Hold and Decreased Target to $43 on, Apr 28th, 2022
Daniel Grosslight of Citigroup, Downgraded "Teladoc Health, Inc." (TDOC) to Hold and Decreased Target from $115 to $43 on, Apr 28th, 2022.
Daniel has made no other calls on TDOC in the last 4 months.
There are 11 other peers that have a rating on TDOC. Out of the 11 peers that are also analyzing TDOC, 4 agree with Daniel's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Kevin Caliendo of "UBS" Maintained at Hold with Decreased Target to $72 on, Tuesday, March 8th, 2022
- David Grossman of "Stifel" Maintained at Hold with Decreased Target to $74 on, Wednesday, February 23rd, 2022
- Steve Valiquette of "Barclays" Maintained at Hold with Decreased Target to $77 on, Wednesday, February 23rd, 2022
- Glen Santangelo of "Jefferies" Maintained at Hold with Decreased Target to $82 on, Monday, February 7th, 2022
These are the ratings of the 7 analyists that currently disagree with Daniel
- Jessica Tassan of "Piper Sandler" Maintained at Buy with Decreased Target to $104 on, Tuesday, March 8th, 2022
- John Eade of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $95 on, Thursday, March 3rd, 2022
- Jailendra Singh of "Credit Suisse" Maintained at Buy with Decreased Target to $114 on, Friday, February 25th, 2022
- Donald Hooker of "Keybanc" Maintained at Buy with Decreased Target to $100 on, Wednesday, February 23rd, 2022
- Lisa Gill of "JP Morgan" Maintained at Buy with Decreased Target to $125 on, Wednesday, February 23rd, 2022
- Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $130 on, Wednesday, February 23rd, 2022
- Cindy Motz of "Goldman Sachs" Initiated at Strong Buy and Held Target at $121 on, Friday, February 11th, 2022
